Today we do a round-up of some of the recent semaglutide trials. Does semaglutide ever miss? But what about tirzepatide, which causes even more weight loss?
We also review two new critical care trials, FLUID and the UK-ROX, new platelet transfusion guidelines, and a new retrospective study of apixaban vs rivaroxaban vs warfarin.
Oral Semaglutide for Diabetes with Cardiovascular Disease or CKD (SOUL)
Semaglutide for Peripheral Artery Disease (STRIDE)
Semaglutide for MASH (ESSENCE)
Semaglutide vs Tirzepatide for Obesity (SURMOUNT-5)
Normal Saline vs Lactated Ringers (FLUID)
Conservative Oxygen Targets in Mechanically Ventilated Patients (UK-ROX)
Platelet Transfusion Guidelines
Apixaban vs Rivaroxaban vs Warfarin
Music from Uppbeat (free for Creators!):
https://uppbeat.io/t/soundroll/dope
License code: NP8HLP5WKGKXFW2R
View all episodes
By Stephen Jenkins, MD, Austin Rupp, MD
4.9
4343 ratings
Today we do a round-up of some of the recent semaglutide trials. Does semaglutide ever miss? But what about tirzepatide, which causes even more weight loss?
We also review two new critical care trials, FLUID and the UK-ROX, new platelet transfusion guidelines, and a new retrospective study of apixaban vs rivaroxaban vs warfarin.
Oral Semaglutide for Diabetes with Cardiovascular Disease or CKD (SOUL)
Semaglutide for Peripheral Artery Disease (STRIDE)
Semaglutide for MASH (ESSENCE)
Semaglutide vs Tirzepatide for Obesity (SURMOUNT-5)
Normal Saline vs Lactated Ringers (FLUID)
Conservative Oxygen Targets in Mechanically Ventilated Patients (UK-ROX)
Platelet Transfusion Guidelines
Apixaban vs Rivaroxaban vs Warfarin
Music from Uppbeat (free for Creators!):
https://uppbeat.io/t/soundroll/dope
License code: NP8HLP5WKGKXFW2R
171,958 Listeners
321 Listeners
555 Listeners
499 Listeners
761 Listeners
3,362 Listeners
112,904 Listeners
56,561 Listeners
1,153 Listeners
99,119 Listeners
78 Listeners
67 Listeners
426 Listeners
172 Listeners